When all tumor types were batched together, DC2-high tumors (top quartile) showed significantly improved survival compared with DC2-low (bottom quartile), while the DC1 and immune response signatures displayed no effect on survival (Figure 2A). This evidence concerns the gene ZDHHC4 and neoplasm.